Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$11.38 CAD
Change Today +0.22 / 1.97%
Volume 4.8K
COM On Other Exchanges
As of 3:56 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William L. Hunter M.D., Msc, BSc

Chief Executive Officer, President and Director, Cardiome Pharma Corp.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 4 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. William L. Hunter, also known as Bill, MD, M.Sc., has been the Chief Executive Officer and President at Cardiome Pharma Corp. since July 2012. Dr. Hunter serves as a Member of Angiotech Pharmaceuticals Inc.'s scientific and management teams. He serves as Senior Advisor of Bml Canada Limited and Rosetta Capital Limited, Investment Arm, and Advisor at Bioscience Managers Pty Ltd. He founded Angiotech Pharmaceuticals Inc. in 1992 and served as its Chief Executive Officer ...

Read Full Background

Corporate Headquarters*

Vancouver, British Columbia V6J 4S7


Phone: 604-677-6905
Fax: 604-677-6915

Board Members Memberships*

Non-executive Director
Chief Executive Officer, President and Director
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee


MS 1989
University Of British Columbia
MD 1992
University Of British Columbia
BS 1985
McGill University

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$650,000

Stock Options*

Total Value of OptionsC$3,697,000
Total Number of Options506,000

Total Compensation*

Total Annual Cash CompensationC$1,170,000
Total Short Term CompensationC$650,000
Total Calculated CompensationC$1,642,236
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COM:CN C$11.38 CAD +0.22


Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Albert David Friesen Ph.D.Founder, Chairman and Chief Executive Officer
Medicure Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOME PHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at